Glioma : Oligodendroglioma or Astrocytoma Clinical Trial
Official title:
Molecular and Cellular Print Medical Device Validation in Adult Glioma Tumors
The purpose of the study is to determine the clinical safety and operability of the innovative tissue imprint device ProTool.
Current limitations in the management of high grade brain tumors partly reside in the lack of
access to pathological tissue.
Conventional biopsy devices can cause severe side effects, thus limiting the amount of tissue
that can be collected for molecular characterization. The Brain-Tissue-Imprint Devices
evaluated in this trial offers a unique opportunity to perform multiple non-lesion sampling
in both tumor tissue and peritumoral areas. The approach relies on the use of tailored
silicon chips integrated in surgical devices enabling tissue sampling through a brief
"silicon to tissue contact", thus limiting potential side effects, and opening a way to
extensive molecular investigation of brain tumors and their microenvironment.
;